John B. Moriarty - 09 Aug 2023 Form 4 Insider Report for Mirati Therapeutics, Inc.

Role
Chief Legal Officer
Signature
/s/ Betsy Gelfand, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
09 Aug 2023
Net transactions value
+$824,989
Form type
4
Filing time
10 Aug 2023, 16:22:43 UTC
Previous filing
23 Jun 2023
Next filing
23 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Award $824,989 +22,297 +45% $37.00 71,660 09 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of Restricted Stock Units (RSUs). Shares will vest 100% on the one year anniversary of the grant date.